IMDEX LIMITED (IMD)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

IMD - IMDEX LIMITED

FNArena Sector : Mining Sector Contracting
Year End: June
GICS Industry Group : Materials
Debt/EBITDA: 1.03
Index: ASX300 | ALL-ORDS

Imdex is an Australian mining tech company. It manufacturers & provides drilling fluids, chemicals, mining instumentation and data & geo-analytical services. Formed in 1980, it became a listed company in 1987.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$2.63

20 Nov
2024

-0.020

OPEN

$2.62

-0.75%

HIGH

$2.65

492,086

LOW

$2.59

TARGET
$2.23 -15.2% downside
Franking for last dividend paid out: 100%
OTHER COMPANIES IN THE SAME SECTOR
ALQ . ANG . ARI . C79 . CDA . CDD . DOW . EHL . GNG . IPG . IPL . LBL . LYL . MAD . MAH . MIN . MLG . MND . MSV . MYE . NWH . ORI . PRN . RAN . RCR . RDG . RUL . SGH . SRG . SXE . XRF .
FNARENA'S MARKET CONSENSUS FORECASTS
IMD: 1
Title FY23
Actual		 FY24
Actual		 FY25
Forecast		 FY26
Forecast
EPS (cps) xxx 6.4 9.5 xxx
DPS (cps) xxx 2.8 3.2 xxx
EPS Growth xxx - 20.0% 50.0% xxx
DPS Growth xxx - 22.2% 15.2% xxx
PE Ratio xxx N/A 26.4 xxx
Dividend Yield xxx N/A 1.3% xxx
Div Pay Ratio(%) xxx 44.0% 33.8% xxx

Dividend yield today if purchased 3 years ago: 0.98%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

 1.11

Estimated Dividend Growth
(Average Of Past Three Years)

  %

Amount Invested

 $ 

Tell Me The Dividend After This Many Years
Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 25/09 - ex-div 1.30c (franking 100%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2024 FactSet UK Limited. All rights reserved
Title 201920202021202220232024
EPS Basic xxxxxxxxxxxxxxx6.4
DPS All xxxxxxxxxxxxxxx2.8
Sales/Revenue xxxxxxxxxxxxxxx445.3 M
Book Value Per Share xxxxxxxxxxxxxxx111.9
Net Operating Cash Flow xxxxxxxxxxxxxxx108.0 M
Net Profit Margin xxxxxxxxxxxxxxx7.28 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201920202021202220232024
Return on Capital Employed xxxxxxxxxxxxxxx5.75 %
Return on Invested Capital xxxxxxxxxxxxxxx4.80 %
Return on Assets xxxxxxxxxxxxxxx4.07 %
Return on Equity xxxxxxxxxxxxxxx5.75 %
Return on Total Capital xxxxxxxxxxxxxxx9.94 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx60.3 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201920202021202220232024
Short-Term Debt xxxxxxxxxxxxxxx34 M
Long Term Debt xxxxxxxxxxxxxxx94 M
Total Debt xxxxxxxxxxxxxxx128 M
Goodwill - Gross xxxxxxxxxxxxxxx325 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx47 M
Price To Book Value xxxxxxxxxxxxxxx1.98

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201920202021202220232024
Capex xxxxxxxxxxxxxxx33.5 M
Capex % of Sales xxxxxxxxxxxxxxx7.53 %
Cost of Goods Sold xxxxxxxxxxxxxxx306 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx69 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx11 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.2

No. Of Recommendations

5
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Citi

xx/xx/xxxx

5

xxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Bell Potter

xx/xx/xxxx

3

xxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

UBS

22/08/2024

1

Buy

$2.35

-10.65%

UBS found the FY24 result from Imdex  "in line". The outlook signalled a relatively flat market and the broker notes the stock sold off as consensus growth expectations were optimistic.

UBS points out this relates to the exploration cycle where activity levels are "stubbornly benign" despite "healthy" gold prices.

The merits of the Devico acquisition continue to shine, the broker adds, delivering revenue growth of 9% despite a down market. Buy rating retained. Target is raised slightly to $2.35.

FORECAST
UBS forecasts a full year FY25 EPS of 9.00 cents.
UBS forecasts a full year FY26 EPS of 11.00 cents.

Morgans

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Macquarie

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial
Access Stockbroker Research History >
EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

2

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Canaccord Genuity

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Jarden

27/08/2024

2

Overweight

$2.30

-12.55%

Imdex reported underlying earnings in line with Jarden. The company is edging closer to the upswing but rebasing earnings first, the broker notes.

While FY24 was largely in line from an operating result perspective, Jarden suggests the outlook into FY25 remains mixed. Imdex has signalled 'flat market activity' into FY25 which, without industry benchmark exploration budgets being set, is yet to meaningfully demonstrate any uplift.

Balancing the potential for a more positive earnings outlook come 2025, the broker materially rebases earnings forecasts and growth expectations, now having greater confidence the risk/reward dynamics have improved.

Upgrade to Overweight from Neutral. Target unchanged at $2.30.

FORECAST
Jarden forecasts a full year FY25 dividend of 3.20 cents and EPS of 9.70 cents.
Jarden forecasts a full year FY26 dividend of 3.90 cents and EPS of 11.90 cents.
Access Extra Coverage Research History >

IMD STOCK CHART

FNArena News on IMD

1
Australian Broker Call *Extra* Edition – Oct 21, 2024

Oct 21 2024 - Daily Market Reports
2
Rudi’s View: Ten Highflyers With More Upside Potential

Oct 02 2024 - Rudi's View
3
Weekly Ratings, Targets, Forecast Changes – 27-09-24

Sep 30 2024 - Weekly Reports
4
Rudi’s View: Defensives, Healthcare, Resources & Data Centres

Sep 19 2024 - Rudi's View
5
Australian Broker Call *Extra* Edition – Aug 27, 2024

Aug 27 2024 - Daily Market Reports

Latest Mining Sector Contracting News

1
Orica Well Positioned To Capitalise

Nov 18 2024 - Australia
2
Risk Seems To The Upside For NRW Holdings

Aug 26 2024 - Small Caps
3
Monadelphous Shakes Off Lithium

Aug 22 2024 - Small Caps
4
Imdex’s Operational Leverage Attracts

Jun 06 2024 - Small Caps
5
Orica Resumes Up-Trend

Apr 16 2024 - Technicals
6
Treasure Chest: Orica’s Technology Tailwind

Nov 21 2023 - Treasure Chest
7
Orica’s Green Ambitions Well-Received

Sep 25 2023 - Australia
8
Gold & Copper Add Confidence To DDH1’s Future

Feb 08 2023 - Small Caps
9
Mader Group Targets US Growth

Dec 22 2022 - Small Caps
10
Perenti Pleases with Guidance Upgrade

Dec 22 2022 - Small Caps